HealthTap Virtual Primary Care
24/7 access to board-certified doctors via video, text, and phone
Company profile
Company profile
HealthTap is a digital health company that provides comprehensive telemedicine and virtual care services to patients seeking convenient access to healthcare. The platform connects users with a network of licensed physicians for virtual consultations via video, messaging, and phone. HealthTap offers on-demand medical advice, prescription services, and health information powered by its proprietary AI technology. The company serves both individual consumers and enterprise clients including employers and health plans seeking to provide accessible, affordable healthcare solutions to their members. HealthTap's platform combines human medical expertise with artificial intelligence to deliver personalized health guidance and clinical care remotely. The service aims to make quality healthcare more accessible by removing geographic and time barriers, allowing patients to consult with doctors from anywhere at any time. HealthTap's technology platform supports a range of clinical services from primary care consultations to specialist referrals, prescription management, and ongoing care coordination.
Company description HealthTap official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
24/7 access to board-certified doctors via video, text, and phone
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of the American Medical Informatics Association : JAMIA · Jun 1, 2026
Advising patients on the use of non-alcoholic beverages that mirror alcohol.Preventive medicine reports · Nov 1, 2024
Diagnostic accuracy of GPT-4 on common clinical scenarios and challenging cases.Learning health systems · Jul 1, 2024
Women's Questions About Perinatal Cannabis Use and Health Care Providers' Responses.Journal of women's health (2002) · Jul 1, 2020
Online patient-provider cannabis consultations.Preventive medicine · Mar 1, 2020
Online Patient-Provider E-cigarette Consultations: Perceptions of Safety and Harm.American journal of preventive medicine · Dec 1, 2016
Clinical validation
NCT03263169 · Mentioned · UNKNOWN
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on HealthTap's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-enhanced telemedicine platforms, virtual care delivery systems, AI-powered triage, or virtual health assistants that facilitate remote clinical consultations between patients and healthcare providers. Includes integrated telehealth platforms with AI capabilities for scheduling, triage, and follow-up care.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.